Financial Health Assessment: MEL AVIATION COMPONENTS LIMITED

1. Financial Health Score: B+

Explanation: The patient is exhibiting robust vitality and exceptional growth, but is suffering from a mild case of "cash flow restriction" typical of rapid expansion. The top-line revenue and operating profit are incredibly strong, and the balance sheet is healthy. However, the relatively low cash reserves against the scale of operations, combined with a slight contraction in gross margin, suggest the business is running hot and requires careful monitoring of its working capital "oxygen supply" to avoid overextension.

2. Key Vital Signs

• Heart Rate (Revenue Growth): Accelerated. Turnover has surged from £7.4m in 2021 to £34.4m in 2024—a nearly five-fold increase over three years. Year-over-year growth from 2023 to 2024 was a strong 17%. The patient's heart is pumping vigorously.
• Blood Pressure (Profitability): Healthy, but with a slight dip. Operating profit rose from £6.6m to £6.9m, which is excellent. However, the gross margin contracted from 29.7% to 27.0%. This is akin to a slight rise in blood pressure—manageable, but it indicates cost pressures or pricing changes that need to be watched.
• Oxygen Levels (Cash & Liquidity): Constrained. Despite £34.4m in turnover, cash on hand is only £200,813. For a company of this size, this is a relatively thin airway. The business is clearly breathing, but it relies heavily on the timely collection of debtors and external financing to keep the oxygen flowing.
• Cholesterol (Leverage): Moderate. Total liabilities stand at £22.3m against net assets of £13.0m. The debt-to-equity ratio is roughly 1.7:1. This isn't an emergency, but it does mean the company is carrying a significant amount of financial "weight" that requires regular servicing.
• Digestive System (Working Capital Cycle): Improving. Debtors days have improved significantly from 73 to 56 days, meaning the company is collecting cash faster. Creditor days have dropped from 107 to 66 days, meaning it is paying suppliers faster. While paying suppliers promptly is often healthy, the rapid reduction in creditor days puts additional pressure on cash flow.

3. Diagnosis

Diagnosis: Hyper-growth with Working Capital Strain

MEL Aviation Components is a classic case of a business scaling rapidly. The underlying business model is clearly very profitable—generating £6.9m in operating profit on £34.4m of revenue is a superb result. However, the business is experiencing "growing pains," specifically in its cash cycle.

The low cash reserves relative to turnover, combined with the recent dividend payout of £1.2m, indicate that nearly every penny generated is being reinvested back into the business (likely in stock/inventory, given the nature of the aviation components sector) or used to service debt and pay shareholders. The recent refinancing with HSBC post-year-end acts as a necessary "transfusion" to fund this continued expansion, confirming that internal cash generation alone isn't quite sufficient to fund the growth trajectory. The slight erosion of gross margin is a symptom of either increased material costs, supply chain pressures, or a shift in product mix toward lower-margin items.

4. Recommendations

• Fluid Resuscitation (Cash Flow Management): Continue to monitor cash flow meticulously. The new HSBC facility provides essential liquidity, but management should ensure this debt is used to fund revenue-generating stock, not to mask underlying cash flow deficits.
• Dietary Adjustments (Margin Protection): Investigate the 2.7% drop in gross margin. In a high-growth phase, it is easy to chase revenue at the expense of margin. The company needs to ensure its pricing strategies keep pace with any inflation in material or operational costs.
• Physical Therapy (Working Capital Optimization): The improvement in debtor days to 56 is excellent—keep this up. However, the halving of creditor days (from 107 to 66) means the company is losing a vital source of free "trade credit" financing. Unless supplier discounts are being negotiated for early payment, try to extend creditor days slightly to better match the cash collection cycle and ease liquidity pressure.
• Pacing (Growth vs. Dividend): While the £1.2m dividend is a healthy reward for shareholders, the relatively low cash balance suggests the company should carefully balance shareholder returns with the need to internally fund its rapid expansion.